453 related articles for article (PubMed ID: 19761691)
1. Discrimination between Sjögren's and non-Sjögren's sicca syndrome by sialoscintigraphy and antibodies against alpha-fodrin and Ro/La autoantigens.
Chen KS; Jiang MC; Li CJ; Liu OK; Tsai CS
J Int Med Res; 2009; 37(4):1088-96. PubMed ID: 19761691
[TBL] [Abstract][Full Text] [Related]
2. Alpha-fodrin autoantibodies are reliable diagnostic markers for juvenile and adult Sjogren's syndrome.
Lawind MF; Alyasky A; Elwan NM; Mourad H; Al-Bendary A
Egypt J Immunol; 2004; 11(1):75-81. PubMed ID: 15724389
[TBL] [Abstract][Full Text] [Related]
3. The importance of alpha-fodrin antibodies in the diagnosis of Sjögren's syndrome.
Turkçapar N; Olmez U; Tutkak H; Duman M
Rheumatol Int; 2006 Feb; 26(4):354-9. PubMed ID: 15990993
[TBL] [Abstract][Full Text] [Related]
4. Intracellular trafficking and surface expression of SS-A (Ro), SS-B (La), poly(ADP-ribose) polymerase and alpha-fodrin autoantigens during apoptosis in human salivary gland cells induced by tumour necrosis factor-alpha.
McArthur C; Wang Y; Veno P; Zhang J; Fiorella R
Arch Oral Biol; 2002 Jun; 47(6):443-8. PubMed ID: 12102760
[TBL] [Abstract][Full Text] [Related]
5. Antibodies against alpha-fodrin are associated with sicca syndrome in the general population.
Witte T; Matthias T; Bierwirth J; Schmidt RE
Ann N Y Acad Sci; 2007 Jun; 1108():414-7. PubMed ID: 17894005
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic markers of Sjögren's syndrome.
Witte T
Dev Ophthalmol; 2010; 45():123-128. PubMed ID: 20502032
[TBL] [Abstract][Full Text] [Related]
7. Detection of cleaved alpha-fodrin autoantigen in Sjögren's syndrome: apoptosis and co-localisation of cleaved alpha-fodrin with activated caspase-3 and cleaved poly(ADP-ribose) polymerase (PARP) in labial salivary glands.
Wang Y; Virji AS; Howard P; Sayani Y; Zhang J; Achu P; McArthur C
Arch Oral Biol; 2006 Jul; 51(7):558-66. PubMed ID: 16405863
[TBL] [Abstract][Full Text] [Related]
8. The Potential Role for Early Biomarker Testing as Part of a Modern, Multidisciplinary Approach to Sjögren's Syndrome Diagnosis.
Beckman KA; Luchs J; Milner MS; Ambrus JL
Adv Ther; 2017 Apr; 34(4):799-812. PubMed ID: 28283891
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of autoantibodies recognizing Sjögren's syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren's syndrome.
Goëb V; Salle V; Duhaut P; Jouen F; Smail A; Ducroix JP; Tron F; Le Loët X; Vittecoq O
Clin Exp Immunol; 2007 May; 148(2):281-7. PubMed ID: 17286756
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostics of Sjögren's syndrome by means of anti-alpha-fodrin antibody].
Tilch DA; Schäfer HG; Winter R
Klin Monbl Augenheilkd; 2007 May; 224(5):427-30. PubMed ID: 17516374
[TBL] [Abstract][Full Text] [Related]
11. Salivary gland and peripheral blood T helper 1 and 2 cell activity in Sjögren's syndrome compared with non-Sjögren's sicca syndrome.
van Woerkom JM; Kruize AA; Wenting-van Wijk MJ; Knol E; Bihari IC; Jacobs JW; Bijlsma JW; Lafeber FP; van Roon JA
Ann Rheum Dis; 2005 Oct; 64(10):1474-9. PubMed ID: 15817659
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and prognostic significance of measuring antibodies to alpha-fodrin compared to anti-Ro-52, anti-Ro-60, and anti-La in primary Sjögren's syndrome.
Locht H; Pelck R; Manthorpe R
J Rheumatol; 2008 May; 35(5):845-9. PubMed ID: 18381788
[TBL] [Abstract][Full Text] [Related]
13. IgA and IgG autoantibodies against alpha-fodrin as markers for Sjögren's syndrome. Systemic lupus erythematosus.
Witte T; Matthias T; Arnett FC; Peter HH; Hartung K; Sachse C; Wigand R; Braner A; Kalden JR; Lakomek HJ; Schmidt RE
J Rheumatol; 2000 Nov; 27(11):2617-20. PubMed ID: 11093442
[TBL] [Abstract][Full Text] [Related]
14. Anti-alpha-fodrin antibodies in Sjögren's syndrome in children.
Maeno N; Takei S; Imanaka H; Oda H; Yanagi K; Hayashi Y; Miyata K
J Rheumatol; 2001 Apr; 28(4):860-4. PubMed ID: 11327263
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of alpha-fodrin antibodies in patients with chronic hepatitis C infection and Sjögren syndrome.
Potthoff A; Witte T; Rifai K; Hoy L; Deterding K; Feyerabend S; Manns MP; Wedemeyer H
Scand J Gastroenterol; 2009; 44(8):994-1003. PubMed ID: 19462335
[TBL] [Abstract][Full Text] [Related]
16. The complexity of Sjögren's syndrome: novel aspects on pathogenesis.
Jonsson R; Vogelsang P; Volchenkov R; Espinosa A; Wahren-Herlenius M; Appel S
Immunol Lett; 2011 Dec; 141(1):1-9. PubMed ID: 21777618
[TBL] [Abstract][Full Text] [Related]
17. [Sjögren's syndrome].
Yoshida S
Nihon Rinsho; 1999 Feb; 57(2):360-3. PubMed ID: 10078005
[TBL] [Abstract][Full Text] [Related]
18. Antifodrin antibodies in Sjogren's syndrome: a review.
Witte T
Ann N Y Acad Sci; 2005 Jun; 1051():235-9. PubMed ID: 16126964
[TBL] [Abstract][Full Text] [Related]
19. Centromere protein C is a target of autoantibodies in Sjögren's syndrome and is uniformly associated with antibodies to Ro and La.
Pillemer SR; Casciola-Rosen L; Baum BJ; Rosen A; Gelber AC
J Rheumatol; 2004 Jun; 31(6):1121-5. PubMed ID: 15170924
[TBL] [Abstract][Full Text] [Related]
20. The epitope study of alpha-fodrin autoantibody in primary Sjögren's syndrome.
Chen Q; Li X; He W; Zhang H; Gao A; Cheng Y; Lei J; Li S; Zeng L
Clin Exp Immunol; 2007 Sep; 149(3):497-503. PubMed ID: 17614976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]